Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064

---
identifier: "/us/fr/04-2397"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064"
title_number: 0
title_name: "Federal Register"
section_number: "04-2397"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064"
positive_law: false
currency: "2004-02-05"
last_updated: "2004-02-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-2397"
document_type: "notice"
publication_date: "2004-02-05"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 5547"
fr_volume: 69
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus Prevention Projects for Community-Based Organizations, Program Announcement Number 04064.

*Times and Dates:* 1 p.m.-4 p.m., February 22, 2004 (Open); 9 a.m.-5 p.m., February 23, 2004 (Closed); 9 a.m.-5 p.m., February 24, 2004 (Closed); 9 a.m.-5 p.m., February 25, 2004 (Closed); 9 a.m.-5 p.m., February 26, 2004 (Closed); 9 a.m.-5 p.m., February 27, 2004 (Closed); 9 a.m.-12 p.m., February 28, 2004 (Closed).

*Place:* The Westin Atlanta North at Perimeter Center, 7 Concourse Parkway,  Atlanta, GA 30328, Telephone (770) 395-3900.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement Number 04064.

*For Further Information Contact:* Beth Wolfe, Resource Funding Analyst, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, Telephone (404) 639-8531.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: January 30, 2004.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.